4//SEC Filing
Lydon Nicholas 4
Accession 0001179110-20-008109
CIK 0001597264other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:25 PM ET
Size
6.8 KB
Accession
0001179110-20-008109
Insider Transaction Report
Form 4
Lydon Nicholas
Director
Transactions
- Sale
Common Stock
2020-07-06$80.44/sh−25,407$2,043,739→ 48,340 total - Sale
Common Stock
2020-07-06$81.02/sh−600$48,612→ 47,740 total
Footnotes (3)
- [F1]Effected pursuant to a trading plan adopted on February 27, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.07 per share.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001639935
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:25 PM ET
- Size
- 6.8 KB